SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549
                                ----------------

                                  SCHEDULE 13D
                                 (Rule 13d-101)

             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
            TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
                                  RULE 13d-2(a)

                               (Amendment No. 14)

                          Consolidated-Tomoka Land Co.
--------------------------------------------------------------------------------
                                (Name of Issuer)

                     Common Stock, par value $1.00 per share
--------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    210226106
--------------------------------------------------------------------------------
                                 (CUSIP Number)

                                David J. Winters
                            Wintergreen Advisers, LLC
                          333 Route 46 West, Suite 204
                        Mountain Lakes, New Jersey 07046
                                 (973) 263-2600
--------------------------------------------------------------------------------
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                April 21, 2008
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of This Statement)

     If the filing person  has previously filed  a statement on  Schedule 13G to
report the  acquisition  that is the subject of this Schedule 13D, and is filing
this  schedule  because  of Rule  13d-1(e),  13d-1(f)  or  13d-1(g),  check  the
following box [ ].

          Note:  Schedules filed in paper format shall include a signed original
     and five copies of the schedule, including all exhibits. See Rule 13d-7 for
     other parties to whom copies are to be sent.

----------
(1)  The  remainder  of this  cover  page  shall be filled  out for a  reporting
     person's  initial  filing on this form with respect to the subject class of
     securities,  and for any subsequent amendment containing  information which
     would alter disclosures provided in a prior cover page.

     The  information  required on the remainder of this cover page shall not be
deemed to be "filed"  for the purpose of Section 18 of the  Securities  Exchange
Act of 1934 or otherwise  subject to the  liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).



CUSIP No. 210226106
          ---------------------

1.   NAME OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     Wintergreen Advisers, LLC

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)  [_]
                                                                 (b)  [x]
3.   SEC USE ONLY



4.   SOURCE OF FUNDS*

     AF

5.   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
     PURSUANT TO ITEMS 2(d) OR 2(e)                                   [_]

6.   CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware, USA

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

7.   SOLE VOTING POWER

     1,481,474


8.   SHARED VOTING POWER

     0

9.   SOLE DISPOSITIVE POWER

     1,481,474

10.  SHARED DISPOSITIVE POWER

     0

11.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     1,481,474

12.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     25.9%

14.  TYPE OF REPORTING PERSON*

     IA



CUSIP No. 210226106
          ---------------------

1.   NAME OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     Wintergreen Fund, Inc.

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)  [_]
                                                                 (b)  [x]
3.   SEC USE ONLY



4.   SOURCE OF FUNDS*

     WC

5.   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
     PURSUANT TO ITEMS 2(d) OR 2(e)                                   [_]

6.   CITIZENSHIP OR PLACE OF ORGANIZATION

     Maryland, USA

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

7.   SOLE VOTING POWER

     0

8.   SHARED VOTING POWER

     564,961

9.   SOLE DISPOSITIVE POWER

     0

10.  SHARED DISPOSITIVE POWER

     564,961

11.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     564,961

12.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     9.9%

14.  TYPE OF REPORTING PERSON*

     IC



CUSIP No. 210226106
          ---------------------

1.   NAME OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     Wintergreen Partners Fund, LP

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)  [_]
                                                                 (b)  [x]
3.   SEC USE ONLY



4.   SOURCE OF FUNDS*

     WC

5.   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
     PURSUANT TO ITEMS 2(d) OR 2(e)                                   [_]

6.   CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware, USA

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

7.   SOLE VOTING POWER

     0

8.   SHARED VOTING POWER

     438,240

9.   SOLE DISPOSITIVE POWER

     0

10.  SHARED DISPOSITIVE POWER

     438,240

11.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     438,240

12.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     7.7%

14.  TYPE OF REPORTING PERSON*

     PN



 CUSIP No. 210226106
           ---------------------

--------------------------------------------------------------------------------
Item 1.  Security and Issuer.

     Consolidated-Tomoka Land Co. (the "Issuer"), Common Stock, par value $1.00
      per share (the "Shares").
     The address of the Issuer is 1530 Cornerstone Boulevard, Suite 100
      Daytona Beach, Florida 32117.
--------------------------------------------------------------------------------
Item 2.  Identity and Background.

(a-c,  f) This  statement  is  being  filed by (i)  Wintergreen  Fund,  Inc,  an
investment  company  registered  under the  Investment  Company Act of 1940,  as
amended ("Wintergreen  Fund"),  (ii) Wintergreen Partners Fund, LP, a US Private
Investment Fund ("Wintergreen Partners") and  (iii) Wintergreen Advisers, LLC, a
Delaware limited liability company ("Wintergreen") which acts as sole investment
manager  of  the  Wintergreen Fund,  Wintergreen Partners  and  other investment
vehicles.  (Each  of Wintergreen Fund, Wintergreen Partners and Wintergreen  may
be referred to herein as a  "Reporting Person"  and collectively may be referred
to as  "Reporting Persons").  The Managing Members of Wintergreen  are  David J.
Winters and Elizabeth N. Cohernour (the "Managing Members"),  each of which is a
citizen  of  the United States.   David J. Winters  is the portfolio manager  at
Wintergreen  and  Elizabeth  N. Cohernour  is the  chief  operating  officer  at
Wintergreen.

The  principal  business and  principal  office  address of each of the Managing
Members, Wintergreen Fund, Wintergreen Partners and Wintergreen  is 333 Route 46
West, Suite 204, Mountain Lakes, New Jersey.

     (d) None of the Managing Members or Reporting Persons have, during the last
five  years,  been  convicted  in  a  criminal  proceeding   (excluding  traffic
violations or similar misdemeanors).

     (e) None of the Reporting  Persons or the Managing Members have, during the
last  five  years,  been  a  party  to  a  civil  proceeding  of a  judicial  or
administrative body of competent jurisdiction and as a result of such proceeding
were or are  subject  to a  judgment,  decree or final  order  enjoining  future
violations  of, or prohibiting  or mandating  activities  subject to, Federal or
state securities laws or finding any violation with respect to such laws.

--------------------------------------------------------------------------------
Item 3.  Source and Amount of Funds or Other Consideration.

As of the date hereof  Wintergreen may  be deemed  to beneficially own 1,481,474
Shares.

As of the date hereof Wintergreen Fund beneficially owns 564,961 Shares.

As of the date hereof Wintergreen Partners beneficially owns 438,240 Shares.

The source of funds used to  purchase  the  securities  reported  herein was the
working capital of Wintergreen  Fund, Wintergreen Partners and other  investment
vehicles  managed by Wintergreen.  The  aggregate  funds  used by the  Reporting
Persons to make the purchases was approximately $95.1 million.

No borrowed  funds were used to purchase  the  Shares,  other than any  borrowed
funds used for working capital purposes in the ordinary course of business.

--------------------------------------------------------------------------------
Item 4.  Purpose of Transaction.

Advisory clients of Wintergreen are the beneficial owners of approximately 25.9%
of the  Issuer's common stock.  Wintergreen  has initiated  discussions with the
Issuer  on  maximizing  the value  of  the  Daytona properties,  through  direct
development or partnerships.  Wintergreen intends to continue its dialogue with,
and to take an active interest in,  the Issuer  to encourage  strategic focus on
the Volusia county properties.  To this end, Wintergreen from time to time, will
communicate with  the Issuer  and  other holders of Common Stock  regarding such
matters.

On April 21, 2008, Wintergreen delivered a letter (the "April 21 Letter") to the
Issuer and  members  of its Board  requesting  the Issuer  postpone  the  Annual
Meeting of Shareholders  of the Issuer  (the "Meeting")  scheduled for April 23,
2008.   In the  April 21 Letter,  Wintergreen requested  that  the Board  of the
Issuer  demonstrate to Wintergreen  and  other shareholders  that  the Corporate
Governance Committee has properly interviewed and nominated independent director
candidates  that  are  truly  independent.   A copy  of  the April 21 Letter  is
attached hereto as Exhibit B and incorporated herein by reference.

Wintergreen may in the future purchase  additional  Shares or dispose of some or
all  of  such  Shares  in  open-market   transactions  or  privately  negotiated
transactions.  Wintergreen  does not currently  have any plans or proposals that
would result  in any of the actions  described in paragraphs  (b) through (j) of
Item 4 of the instructions to Schedule 13D.

--------------------------------------------------------------------------------
Item 5.  Interest in Securities of the Issuer.

(a, b) As of the date  hereof,  Wintergreen  may be deemed to be the  beneficial
owner of 1,481,474 Shares, constituting 25.9% of the Shares of the Issuer, based
upon 5,727,515 Shares outstanding as of the date of this filing.

     Wintergreen has  the sole power to vote or  direct  the  vote of  1,481,474
Shares;  has the shared  power to vote or direct the vote of 0 Shares;  has sole
power to dispose or direct the disposition  of 1,481,474 Shares;  and has shared
power to dispose or direct the disposition of 0 Shares.

Wintergreen  specifically  disclaims beneficial ownership in the Shares reported
herein except to the extent of its pecuniary interest therein.

(a,  b) As of the  date  hereof,  Wintergreen  Fund is the  beneficial  owner of
564,961  Shares (1), constituting  9.9% of the Shares of the Issuer,  based upon
5,727,515 Shares outstanding as of the date of this filing.

     Wintergreen Fund has the sole power to vote or direct the vote of 0 Shares;
has the  shared  power to vote or direct the vote of  564,961  Shares;  has sole
power to dispose or direct the disposition of 0 Shares;  and has shared power to
dispose or direct the disposition of 564,961 Shares.

(1)  Wintergreen  Fund has  delegated all of its authority to vote or dispose of
the Shares to Wintergreen, its investment manager.

(a,  b) As of the date hereof,  Wintergreen  Partners is the beneficial owner of
438,240  Shares (1), constituting  7.7% of the Shares of the Issuer,  based upon
5,727,515 Shares outstanding as of the date of this filing.

     Wintergreen Partners  has the sole power  to vote or  direct the vote  of 0
Shares;  has the shared power to vote or direct the vote of 438,240 Shares;  has
sole power  to dispose or  direct the disposition  of 0 Shares;  and  has shared
power to dispose or direct the disposition of 438,240 Shares.

(1)  Wintergreen Partners  has delegated all of its authority to vote or dispose
of the Shares to Wintergreen, its investment manager.

     (c) Inapplicable.

     (d) Inapplicable.

     (e) Inapplicable.

--------------------------------------------------------------------------------
Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer.

         N/A.

--------------------------------------------------------------------------------
Item 7.  Material to be Filed as Exhibits.

Exhibit A: Agreement between the Reporting Persons to file jointly
Exhibit B: Letter to Board of Directors dated April 21, 2008



--------------------------------------------------------------------------------







                                    SIGNATURE


     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.

Wintergreen Advisers, LLC
By: David J. Winters, Managing Member.

/s/ David J. Winters
______________________________________


Wintergreen Fund, Inc.
By: David J. Winters, Executive Vice President

/s/ David J. Winters
______________________________________


Wintergreen Partners Fund, LP
By: Wintergreen GP, LLC
By: David J. Winters, Managing Member

/s/ David J. Winters
______________________________________
April 22, 2008



Attention.  Intentional  misstatements  or omissions of fact constitute  federal
criminal violations (see 18 U.S.C. 1001).



                                                                Exhibit A


                                    AGREEMENT

The undersigned agree that this Amendment No 14 to Schedule 13D  dated April 22,
2008, relating to the Common Stock,  par value $1.00 per share  of Consolidated-
Tomoka Land Co. shall be filed on behalf of the undersigned.


Wintergreen Advisers, LLC.
By: David J. Winters, Managing Member

/s/ David J. Winters
______________________________________

Wintergreen Fund, Inc.
By: David J. Winters, Executive Vice President

/s/ David J. Winters
______________________________________

Wintergreen Partners Fund, LP
By: Wintergreen GP, LLC
By: David J. Winters, Managing Member

/s/ David J. Winters
______________________________________

Apil 22, 2008


                                                                  Exhibit B

Wintergreen Advisers, LLC
333 Route 46 West
Suite 204
Mountain Lakes, New Jersey 07046

April 21, 2008

Board of Directors
Consolidated-Tomoka Land Co
c/o Linda Crisp, Corporate Secretary
1530 Cornerstone Blvd., Suite 100
Daytona Beach, FL 32117



Dear Board Members:

As of the date of this letter,  Wintergreen Advisers, LLC (the "Adviser") may be
deemed to beneficially own 1,481,474 shares of common stock, par value $1.00 per
share ("Common Stock"),  of Consolidated-Tomoka Land Co. (the "Company"),  which
constitutes 25.9% of the Common Stock. The undersigned, David J. Winters, is the
Managing Member and CEO of the Adviser. The Adviser is the investment adviser to
Wintergreen Fund, Inc. (the "Fund"),  a registered investment company,  which is
the beneficial owner  of 564,961 shares  of Common Stock  (approximately 9.9% of
the outstanding shares).  The Adviser also serves as investment adviser to other
pooled investment vehicles,  which also own additional shares of Common Stock of
the Company  (the Fund,  the other investment vehicles  and the Adviser shall be
referred to collectively herein as "Wintergreen").

Wintergreen respectfully requests  that the Company postpone  its Annual Meeting
of Shareholders,  currently  scheduled  to take place  on  April 23,  2008  (the
"Meeting"),  until  at  least  July 22,  2008  or  such time  as  the Board  can
demonstrate to Wintergreen  and other shareholders that the Corporate Governance
Committee has properly interviewed and nominated independent director candidates
that are truly independent, to be elected at the 2008 Annual Meeting of
Shareholders.

In the event the Company  does not postpone the Meeting,  Wintergreen intends to
withhold authority  for the shares of Common Stock it beneficially owns  to vote
for the election of Directors.

Wintergreen takes significant issue  with the two  independent director nominees
to be presented at the Meeting.  Wintergreen questions how the Board could reach
a determination that William L. Olivari  and William H. Davison  are independent
in accordance with  the Listing Standards of The American Stock Exchange,  which
require that  in order for a director to qualify as independent,  the board must
affirmatively determine  that  the director  does not have  a relationship  that
would interfere  with the exercise  of independent judgment  in carrying out the
responsibilities of a director.

It has come  to  Wintergreen's  attention  that in  2003,  the  Company  sold  a
significant parcel of land (the "Property") on the west side of Daytona Beach to
Halifax  Health  System  ("Halifax")  for  $15.5 million,  one  of  the  largest
transactions in the Company's history.  As part of the purchase arrangement, the
Company retained the right to reacquire the Property  at the original sale price
in the event  Halifax did  not  begin  construction  on one  of  two medical  or
hospital buildings  on the Property  by  December 2005.   Halifax  did not begin
construction  on the  first  building by  December 2005.   According  to  public
statements  by  Halifax  officials,  the Hospital  has no present  intention  of
breaking ground on a medical or hospital facility at the site in the foreseeable
future.    To  Wintergreen's  knowledge,   the   Company  did  not  demand  that
construction begin until December 2007,  which demand caused the Company's right
to repurchase  to vest  in December 2008.   Accordingly,  the Company  has taken
limited action  to enforce  its rights.   Mr. Olivari  has significant  ties  to
Halifax  and  in fact  currently serves  as  the chairperson  of  the  board  of
Halifax's  foundation  and  has served on  that board  for the last  two  years.
Wintergreen believes that Mr.



Olivari has a conflict of interest  related to the Company's enforcement  of its
rights.   Mr. Olivari's  connection  to  Halifax  has not been disclosed  in the
Company's Proxy Statement.

In addition,  Mr. William H. Davison,  a director  of the Company  who is up for
re-election at the Meeting,  served as Chairman,  President  and Chief Executive
Officer  of  SunTrust  Bank  ("SunTrust"),  East  Central  Florida,   until  his
retirement  in September 2007.   As disclosed in  the Company's Proxy Statement,
the Company  and  SunTrust are parties to a Master Loan  and  Security Agreement
pursuant to which  SunTrust has provided  the Company  with a  term loan  in the
amount of $8 million and  an unsecured line of credit  in the maximum amount  of
$20 million.  The Company and SunTrust are also parties to an International Swap
Dealers Association, Inc. Master Agreement with respect to an interest rate swap
in connection with the term loan described above.

The Company, however,  did not contemporaneously disclose in any Proxy Statement
or any of its other public filings a 2004 agreement  with SunTrust Bank pursuant
to which SunTrust purchased  a site in Daytona Beach  from one of  the Company's
subsidiaries  for the purpose of constructing  a regional banking facility.   It
also failed  contemporaneously  to disclose a covenant  in that  agreement  that
obligated SunTrust  to begin  construction  on  the site  by  December 2006,  or
otherwise to permit  the Company  to repurchase  the property  at  the  original
purchase price  of  $1.43 million,  without  penalty  to SunTrust.   Thereafter,
SunTrust did not  begin construction  by 2006 and the Company,  likewise without
advance disclosure to shareholders, repurchased the property for $1.43 million.

While certain of the related party transactions between SunTrust and the Company
have been disclosed  in the Proxy Statement,  the Company's failure  to disclose
the  purchase transactions  involving  the Company  and  Halifax  and  SunTrust,
respectively, begs the question of whether there are other material transactions
the Company may have failed  to disclose to its shareholders.   The transactions
described  above  also  bring  into question  the  process  by which  the  Board
determines the independence of the Company's directors.

Within the last twelve months,  Wintergreen has brought four director candidates
to the attention of the Company.   As the Proxy Statement indicates,  one of the
candidates was rejected  due to  meeting schedule conflicts.  Wintergreen  finds
the rejection  of  an  otherwise  qualified candidate  on these  grounds  to  be
unacceptable.   Even more problematic  is the fact that the Corporate Governance
Committee never contacted  the other  three candidates,  despite the  fact  that
there is currently a vacancy on the Board.

The Board's seemingly lax director independence determination standards  and the
Corporate  Governance  Committee's   refusal  to  seriously  consider  qualified
candidates  for directorships  that Wintergreen  has brought  to their attention
points  to  what  Wintergreen  believes   are  inadequate  corporate  governance
practices of the Company.  Wintergreen has pointed these issues out in the past,
and intends to continue to monitor them.

As we have communicated in our prior correspondence to you  and  in our meetings
with   management,    Wintergreen's  sole  interest   in  the  Company   is  its
participation through its shares of Common Stock  in the creation of shareholder
value for Wintergreen  and the Company's  other shareholders.   Wintergreen  has
proposed a  number of initiatives  for consideration  by the Company  and/or its
shareholders  in  order  to  re-focus  the  Company's  business  operations  and
demonstrate  to shareholders  that management is acting  in the best interest of
all shareholders.   To date, management of the Company has not shown Wintergreen
that it shares the goal of the creation of shareholder value.



Please  direct  any  questions  regarding  the  information  contained  in  this
correspondence to our legal counsel, Patricia Poglinco ((212) 574-1247), or Fola
Adamolekun  ((212) 574-1320),  of Seward & Kissel LLP,  One  Battery Park Plaza,
New York, New York 10004,  or to our special Florida counsel, Ronald Albert, Jr.
((305) 373-9474)  of  Broad and  Cassel,  One Biscayne Tower,  2  South Biscayne
Boulevard, Miami, Florida 33131.

Sincerely yours,

/s/ David J. Winters

David J. Winters, CEO
Wintergreen Advisers, LLC


Cc:     John C. Adams Jr.
        Bob D. Allen
        William H. Davison
        Gerald L. DeGood
        James E. Gardner
        William H. McMunn
        John C. Myers III
        William L. Olivari (Nominee)
        William J. Voges
        Ronald Albert, Jr. Esq.
                Broad and Cassel


-----END PRIVACY-ENHANCED MESSAGE-----